LABORATORIUM FARMACEUTYCZNE AVENA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
LABORATORIUM FARMACEUTYCZNE AVENA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
B
HighReliability
B - HighIncorporation date
20/10/2016Share capital
5,000.00 PLNPrimary activity
Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)Representatives
0Representatives rights
DO REPREZENTOWANIA SPÓŁKI, PRZY POWOŁANIU JEDNOOSOBOWEGO ZARZĄDU SPÓŁKI, UPRAWNIONY JEST JEDNOOSOBOWO POWOŁANY CZŁONEK ZARZĄDU, A W POZOSTAŁYCH PRZYPADKACH - DWÓCH CZŁONKÓW ZARZĄDU ŁĄCZNIE LUB CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEMRepresentatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
804,926Net Profit (zł)
804,926Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 9,427,767 |
| 2,332,174 |
| 1,881,263 |
| 0.60 |
| 5.91 |
| 19.95 |
| 9,097,753 |
| 1,157,061 |
| 0 |
| 3,414,122 |
| 2023 |
|---|
| 7,538,837 |
| 738,052 |
| 585,878 |
| 0.92 |
| 12.03 |
| 7.77 |
| 9,618,091 |
| 627,294 |
| 0 |
| 2,700,529 |
| 2024 |
|---|
| 8,792,980 |
| 1,017,784 |
| 804,926 |
| 0.39 |
| 4.29 |
| 9.15 |
| 8,423,018 |
| 1,051,030 |
| - |
| - |
| 2024 |
|---|
| 8,792,980 |
| 1,017,784 |
| 804,926 |
| 0.39 |
| 4.29 |
| 9.15 |
| 8,423,018 |
| 1,051,030 |
| - |
| - |
Turnover (zł)
2024
Turnover (zł)
8,792,980 zł
17 % *
Profit before tax (zł)
1,017,784 zł38 % *
Net Profit (zł)
804,926 zł37 % *
Working capital requirement (%)
0.39 
-57.61 % *
Liquidity ratio
4.29 
-64.34 % *
Net profitability (%)
9.15 %17.76 % *
Equity (zł)
8,423,018 zł-12 % *
Current liabilities (zł)
1,051,030 zł68 % *
Non current liabilities (zł)
-Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
LABORATORIUM FARMACEUTYCZNE AVENA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
02/07/2025 | OD 01.01.2024 DO 31.12.2024 |
10/07/2024 | OD 01.01.2023 DO 31.12.2023 |
13/07/2023 | OD 01.01.2022 DO 31.12.2022 |
03/10/2022 | OD 01.01.2021 DO 31.12.2021 |
14/10/2021 | OD 01.01.2020 DO 31.12.2020 |